Determining Pattern of Recurrence Following Pancreaticoduodenectomy and Adjuvant 5-Flurouracil-Based Chemoradiation Therapy: Effect of Number of Metastatic Lymph Nodes and Lymph Node Ratio-Reference-Cited by-同舟云学术

Determining Pattern of Recurrence Following Pancreaticoduodenectomy and Adjuvant 5-Flurouracil-Based Chemoradiation Therapy: Effect of Number of Metastatic Lymph Nodes and Lymph Node Ratio

Published:2008-12-17 Issue:4 Volume:13 Page:752-759
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Asiyanbola Bolanle,Gleisner Ana,Herman Joseph M.,Choti Michael A.,Wolfgang Christopher L.,Swartz Michael,Edil Barish H.,Schulick Richard D.,Cameron John L.,Pawlik Timothy M.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11605-008-0762-x.pdf

Reference37 articles.

1. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284–2303. doi: 10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V .

2. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003;237:74–85. doi: 10.1097/00000658-200301000-00011 .

3. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567–579. doi: 10.1016/S1091-255X(00)80105-5 .

4. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248–257. doi: 10.1097/00000658-199709000-00004 , discussion 257–260.

5. Whittington R, Bryer MP, Haller DG, et al. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1991;21:1137–1143.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy;Pancreatology;2024-08

2. Theranostic nanoparticles for detection and treatment of pancreatic cancer;WIREs Nanomedicine and Nanobiotechnology;2024-07

3. Nomogram for Predicting Post-progression-free Survival in Patients with Recurrent Pancreatic Ductal Adenocarcinoma after Radical Surgery;2024-05-28

4. Ductal Adenocarcinoma and Pancreatic Intraepithelial Neoplasia;Tumors of the Pancreas;2023-03

5. Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress;World Journal of Gastrointestinal Surgery;2023-02-27